76 tracked 13F filers disclose a position in DBVT as of the latest SEC 13F filings, a combined $384.4M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | MPM BioImpact LLC | $108.9M | 5.2M | ▲+423% Added · +4.2M sh | Q1 2026 | |
| 2 | Artisan Partners Limited Partnership | $46.4M | 2.2M | ▼−33% Reduced · −1.1M sh | Q1 2026 | |
| 3 | Siren, L.L.C. | $30.5M | 1.9M | —Held | Q2 2026 | |
| 4 | Vivo Capital, LLC | $30.3M | 1.8M | ▼−31% Reduced · −823K sh | Q2 2026 | |
| 5 | BAKER BROS. ADVISORS LP | $30.5M | 1.5M | —Held | Q1 2026 | |
| 6 | ADAR1 Capital Management, LLC | $21.2M | 1.0M | ▲New +1.0M sh | Q1 2026 | |
| 7 | PERCEPTIVE ADVISORS LLC | $20.1M | 964K | ▲New +964K sh | Q1 2026 | |
| 8 | Patient Square Capital LP | $14.9M | 909K | ▲+31% Added · +216K sh | Q2 2026 | |
| 9 | Octagon Capital Advisors LP | $12.0M | 574K | —Held | Q1 2026 | |
| 10 | Ikarian Capital, LLC | Withheld | 525K | —Held | Q1 2026 | |
| 11 | Redmile Group, LLC | $10.3M | 491K | ▼−11% Reduced · −59K sh | Q1 2026 | |
| 12 | Duquesne Family Office LLC | $6.3M | 383K | —Held | Q2 2026 | |
| 13 | MILLENNIUM MANAGEMENT LLC | $6.7M | 319K | ▼−50% Reduced · −322K sh | Q1 2026 | |
| 14 | BALYASNY ASSET MANAGEMENT L.P. | $4.9M | 233K | ▼−0.7% Reduced · −2K sh | Q1 2026 | |
| 15 | AMERIPRISE FINANCIAL INC | $4.8M | 231K | ▲New +231K sh | Q1 2026 | |
| 16 | Ishara Investments LP | $3.0M | 185K | ▲+80% Added · +82K sh | Q2 2026 | |
| 17 | Yiheng Capital Management, L.P. | $3.6M | 170K | ▼−73% Reduced · −470K sh | Q1 2026 | |
| 18 | NEW YORK STATE COMMON RETIREMENT FUND | $3.5M | 168K | ▼−25% Reduced · −55K sh | Q1 2026 | |
| 19 | BOOTHBAY FUND MANAGEMENT, LLC | $3.4M | 163K | —Held | Q1 2026 | |
| 20 | MORGAN STANLEY | $3.1M | 146K | ▲+19% Added · +24K sh | Q1 2026 | |
| 21 | Russell Investments Group, Ltd. | $2.7M | 129K | ▲New +129K sh | Q1 2026 | |
| 22 | ENVESTNET ASSET MANAGEMENT INC | $2.0M | 96K | ▲+327% Added · +73K sh | Q1 2026 | |
| 23 | DIVERSIFY WEALTH MANAGEMENT, LLC | $1.2M | 90K | ▲+41% Added · +26K sh | Q2 2026 | |
| 24 | Diversify Advisory Services, LLC | $1.2M | 90K | ▲New +90K sh | Q2 2026 | |
| 25 | UBS Group AG | $1.7M | 80K | ▼−68% Reduced · −165K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 18 funds opened a new position in DBVT and 7 added to an existing one, while 14 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| ELI LILLY & COLLY | 33 funds | $3.3B |
| NVIDIA CORPNVDA | 32 funds | $15.2B |
| AMAZON.COM INCAMZN | 32 funds | $9.2B |
| ALPHABET INC-CL AGOOGL | 31 funds | $7.9B |
| TAIWAN SEMICONDUCTOR-SP ADRTSM | 31 funds | $4.2B |
| LAM RESEARCH CORPLRCX | 31 funds | $3.0B |
| APPLIED MATERIALS INCAMAT | 31 funds | $2.0B |
| MICROSOFT CORPMSFT | 30 funds | $10.0B |
| BROADCOM INCAVGO | 30 funds | $6.5B |
| ALPHABET INC-CL CGOOG | 30 funds | $6.3B |
| MICRON TECHNOLOGY INCMU | 30 funds | $2.7B |
| ELEVANCE HEALTH INCELV | 30 funds | $2.1B |
Ranked by how many of DBVT's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jul 29, 2026 | Mohideen Pharis | Chief Medical Officer | Sell (S) | 464 | $1K |
| Jan 29, 2026 | Mohideen Pharis | Chief Medical Officer | Sell (S) | 534 | $3K |
| Dec 18, 2025 | EPIC Bpifrance | Insider | Sell (S) | 1.3M | $5.4M |
| Dec 17, 2025 | EPIC Bpifrance | Insider | Sell (S) | 40K | $211K |
| Dec 17, 2025 | EPIC Bpifrance | Insider | Sell (S) | 2.0M | $9.9M |
| Nov 21, 2025 | Mohideen Pharis | Chief Medical Officer | Sell (S) | 2K | $4K |
| Nov 20, 2025 | Mohideen Pharis | Chief Medical Officer | Sell (S) | 6K | $19K |
| Jul 29, 2025 | Mohideen Pharis | Chief Medical Officer | Sell (S) | 464 | $1K |
| May 22, 2025 | Mohideen Pharis | Chief Medical Officer | Sell (S) | 397 | $730 |
| Jan 30, 2025 | Mohideen Pharis | Chief Medical Officer | Sell (S) | 600 | $510 |
| Nov 25, 2024 | Mohideen Pharis | Chief Medical Officer | Sell (S) | 565 | $322 |
| Nov 22, 2024 | Mohideen Pharis | Chief Medical Officer | Sell (S) | 342 | $181 |
Connected entities for DBVT
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/DBVT/capital-change-brief"
Use Arkolith's capital_change_brief for DBVT. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for DBVT. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.